The 20 Best Heart Failure with Preserved Ejection Fraction (HFpEF) Doctors Near Me in Baltimore, MD

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Elite provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Tissue Biopsy. Dr. Sharma is board certified in American Board Of Internal Medicine.

David Kass is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Kass is rated as an Elite provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Hypertension, Pulmonary Fibrosis, and Heart Transplant.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy. Dr. Vaishnav is board certified in American Board Of Internal Medicine.

Lena Mathews specializes in general cardiology and echocardiography. She received her medical degree from University of Pennsylvania School of Medicine and completed an internal medicine residency at Brigham and Women’s Hospital. She completed fellowships in cardiology and echocardiography at the Johns Hopkins University School of Medicine. Dr. Mathews is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Apoplexy, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), and Atherosclerosis. Dr. Mathews is board certified in National Board Of Echocardiography.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Transplant. Dr. Hassoun is board certified in American Board Of Internal Medicine.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.

John Gottdiener is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Gottdiener is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, and Ectopic Heartbeat.

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI). Dr. Gerstenblith is board certified in American Board Of Internal Medicine.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Dr. Monica Mukherjee is an adult cardiologist and an Associate Professor of Medicine at the Johns Hopkins University Division of Cardiology and specializes in advanced cardiac imaging. She serves as Medical Director of the Echocardiography Lab at Johns Hopkins Bayview Medical Center, and as Associate Director of the Johns Hopkins Echocardiography program across the institution. Dr. Mukherjee graduated Summa Cum Laude with dual Bachelors of Science in Psychology and Behavioral Neurosciences from the University of Florida. She received her Doctorate in Medicine from the George Washington University in Washington, DC, and internal medicine residency at Drexel University, before returning to George Washington to complete her fellowship in cardiovascular disease. She has a MPH from the Johns Hopkins Bloomberg School of Public Health with a special concentration in Epidemiological and Biostatistical Methods for Public Health and Clinical Research. Dr. Mukherjee has an accomplished academic career with multiple research awards focused on right ventricular remodeling in heart failure, pulmonary hypertension, and scleroderma. She was the recipient of the 2020 Johns Hopkins University Clinician Scientist Award and also has been funded by the National Institutes of Health, the Scleroderma Foundation, and the CHEST Foundation. She was awarded the Top 25 Young Investigators Award from the American Society of Echocardiography in 2016. Dr. Mukherjee is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Heart Attack, Systemic Sclerosis (SSc), Tissue Biopsy, and Pacemaker Implantation. Dr. Mukherjee is board certified in American Board Of Internal Medicine.

Pamela Ouyang is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Ouyang is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Atherosclerosis, Menopause, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, and Hormone Replacement Therapy (HRT).

Virginia Shalkey Hahn, M.D., is a cardiologist specialized in caring for patients with cardiomyopathy and heart failure. Dr. Hahn received her medical degree from the Perelman School of Medicine at the University of Pennsylvania in 2012. She was a Sarnoff Fellow at Johns Hopkins University School of Medicine. She completed internal medicine residency at the Hospital of the University of Pennsylvania and cardiology/advanced heart failure fellowship at Johns Hopkins Hospital, where she was the Marie-Josée and Henry R Kravis Chief Cardiology Fellow. Dr. Hahn's research is focused on translational studies in heart failure using bioinformatics tools and functional assays. She has won several awards and grants for her research. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, and Apoplexy. Dr. Hahn is board certified in American Board Of Internal Medicine.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant. Dr. Kasper is board certified in American Board Of Internal Medicine.

Dr. Nisha A. Gilotra is a cardiologist in the Johns Hopkins Medicine Division of Cardiology with expertise in advanced heart failure, including the care of heart transplant and ventricular assist device patients. Dr. Gilotra specializes in inflammatory cardiomyopathies, including sarcoidosis, myocarditis and inherited causes of cardiomyopathy. Dr. Gilotra received her medical degree from Jefferson Medical College in Philadelphia, PA. She completed her medical residency, general cardiology fellowship and advanced heart failure fellowship at Johns Hopkins University School of Medicine. Between fellowships, she served as an Assistant Chief of Service for the Department of Medicine. Dr. Gilotra is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Myocarditis, Cardiomyopathy, Heart Transplant, and Endoscopy.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Supraventricular Tachycardia (PSVT), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), His Bundle Tachycardia, Cardiac Ablation, and Tissue Biopsy. Dr. Cingolani is board certified in American Board Of Internal Medicine.

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Atrial Fibrillation, Heart Attack, Pulmonary Hypertension, and Apoplexy. Dr. Wu is board certified in American Board Of Internal Medicine.

Dr. Emmanouil Tampakakis is an Assistant Professor of Medicine at Johns Hopkins University School of Medicine as well as an attending physician at Johns Hopkins Hospital. His research focuses on Stem Cell Biology and Heart Development and Regeneration. Specifically, Dr. Tampakakis lab aims to understanding the biology and regenerative potential of stem cell-derived cardiomyocytes and uses human induced pluripotent stem cells and animal models to model human cardiac disease and deciphering the mechanisms of cardiac maturation. Dr. Tampakakis also holds a cardiology fellowship at Johns Hopkins Hospital. Dr. Tampakakis received his undergraduate degree and M.D. from the University of Crete. He completed an internal medicine residency at Boston University Medical Center. Prior to joining Johns Hopkins in 2012, Dr. Tampakakis was a research fellow in Dr. J. Vita’s laboratory of Vascular Biology at Boston University School of Medicine. At Johns Hopkins, he was a post-doc in the labs of Drs Chulan Kwon and David Kass. Dr. Tampakakis is the recipient of several awards including the AHA outstanding early career investigator award and the ACC Presidential Career Development Award and has received funding from the AHA and the NIH. Videos Meet Our Expert - Emmanouil Tampakakis Recent News Articles and Media Coverage Hopkins researchers discover newborn rats hold secret to manufacturing human heart cells., The Baltimore Sun, (February 11, 2017). Dr. Tampakakis is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Apoplexy, Arterial Embolism, and Heart Failure.

Rani Hasan is an Interventional Cardiologist practicing medicine in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Hasan is board certified in American Board Of Internal Medicine.

Dr. Brian Gustav Kral is Assistant Professor in the Division of Cardiology and General Internal Medicine as well as Assistant Professor of Radiology and Radiological Sciences at the Johns Hopkins School of Medicine. He is currently engaged in research on genetic and biological mechanisms of coronary atherosclerosis with an emphasis on plaque morphology and composition as well as coronary blood flow at different stages of disease progression. Dr. Kral received his undergraduate degree in economics and pre-medicine from The Johns Hopkins University. He received a master’s in public health from The Johns Hopkins School of Public Health. He also earned a medical degree from The Johns Hopkins School of Medicine. Dr. Kral completed his residency at the Mayo Graduate School of Medicine. He rejoined the Johns Hopkins community as a fellow in 2005 where he remained on Faculty after completion of his training. Besides his teaching and clinical engagements, Dr. Kral is currently the Program Director of Nuclear Cardiology at the Johns Hopkins School of Medicine. Dr. Kral is also Director of Clinical Studies for The Johns Hopkins GeneSTAR Research Program. The program aims to identify genetic and biological determinants of subclinical and clinical atherosclerotic disease and thrombosis in individuals with a strong family history of early-onset coronary artery disease. He has been recognized with the Stanley L. Blumenthal Cardiology Research Award for outstanding clinical research in cardiovascular disease from The Johns Hopkins Medical Institutions. Dr. Kral is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Apoplexy, Coronary Heart Disease, Heart Attack, Pacemaker Implantation, and Aortic Valve Replacement. Dr. Kral is board certified in American Board Of Internal Medicine.